Pulmonary alveolar proteinosis complicated by pulmonary and intracranial cryptococcal infection: A case report

Chun-Xing Ye1, Huan-Qing Lin1, Zi-Ran Wang2

  • 1Department of Respiratory Medicine, Longgang Central Hospital, Shenzhen, Guangdong Province, China.

Medicine
|July 29, 2025
PubMed
Abstract

Insights

Pulmonary alveolar proteinosis (PAP) can rarely present with Cryptococcus gattii infection. Early diagnosis and multifaceted treatment are crucial for managing this rare opportunistic infection in PAP patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Radiology

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease.
  • Opportunistic Cryptococcus gattii infection can complicate PAP management.
  • This case highlights a rare co-infection scenario.

Purpose of the Study:

  • To report a case of Pulmonary Alveolar Proteinosis (PAP) with superimposed Cryptococcus gattii infection.
  • To emphasize the diagnostic challenges and treatment strategies for this rare co-infection.
  • To underscore the importance of comprehensive diagnostic approaches.

Main Methods:

  • A 34-year-old male with a 2-month cough presented with PAP.
  • Diagnosis confirmed by CT scan, lung biopsy, and lavage fluid/CSF cultures.
  • Next-generation sequencing of lung tissue identified Cryptococcus infection.

Main Results:

  • Induction therapy included Amphotericin B, fluconazole, and flucytosine.
  • Surgical intervention (right lower lobectomy) and voriconazole were administered postoperatively.
  • Patient showed clinical improvement with declining CSF cryptococcal antigen and reduced brain lesions on MRI.

Conclusions:

  • PAP patients are susceptible to rare opportunistic infections like C. gattii.
  • Multifaceted diagnostic examinations are essential for identifying C. gattii.
  • Close monitoring for adverse reactions (liver/kidney damage, thrombosis) during C. gattii treatment is vital.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
362
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
326
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
442
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
565
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
366
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
122